| Patents for A61K 38 - Medicinal preparations containing peptides (316,240) |
|---|
| 08/17/2005 | EP1512007A4 32235, a human aminotransferase family member and uses therefor |
| 08/17/2005 | EP1495045A4 Cytoplasmic transduction peptides and uses thereof |
| 08/17/2005 | EP1466174A4 Mutations in the bcr-abl tyrosine kinase associated with resistance to sti-571 |
| 08/17/2005 | EP1461445A4 Glycoprotein remodeling using endoglycanases |
| 08/17/2005 | EP1429617A4 Methods for sterilizing preparations of digestive enzymes |
| 08/17/2005 | EP1427830A4 Bv8 NUCLEIC ACIDS AND POLYPEPTIDES WITH MITOGENIC ACTIVITY |
| 08/17/2005 | EP1411978A4 Botulinum toxin in the treatment or prevention of acne |
| 08/17/2005 | EP1354597B1 Pharmaceutical combination for the treatment of tissue damage owing to an arterial irrigation defect |
| 08/17/2005 | EP1289951B1 Growth hormone secretagogues |
| 08/17/2005 | EP1254141B1 Camptothecin -beta-alanine esters with topoisomerase i inibhition |
| 08/17/2005 | EP1248643B1 The use of copolymer 1 and related peptides and polypeptides and t cells treated therewith for neuroprotective therapy |
| 08/17/2005 | EP1225913B1 Use of nitric oxide for the treatment of airway constriction |
| 08/17/2005 | EP1224215B1 NON-ANAPHYLACTIC FORMS OF GRASS POLLEN Ph1 p 6 ALLERGEN AND THEIR USE |
| 08/17/2005 | EP1161250B1 Immunostimulant bacterial membrane fractions in cancer treatment |
| 08/17/2005 | EP1109908B1 Methods for determining compounds for modulating the body weight |
| 08/17/2005 | EP1087775B1 Preventing cerebral infarction through administration of adp-receptor antiplatelet and antihypertensive drugs in combination |
| 08/17/2005 | EP1073723B1 Ste20-related protein kinases |
| 08/17/2005 | EP1051500B1 Diagnosis and treatment of aur1 and/or aur2 related disorders |
| 08/17/2005 | EP1025119B1 Histogranin peptide and their analgesic use |
| 08/17/2005 | EP1023445B1 Cadherin derived growth factor and the application thereof |
| 08/17/2005 | EP1023067B9 The use of inhibitors of the renin-angiotensin system for the treatment of hypoxia or impaired metabolic function |
| 08/17/2005 | EP1011710B1 Methods and compositions for optimization of oxygen transport by cell-free systems |
| 08/17/2005 | EP1003478B1 Aqueous aerosol preparations containing biologically active macromolecules and method for producing the corresponding aerosols |
| 08/17/2005 | EP0994718B1 Gonadotropin releasing hormone antagonist |
| 08/17/2005 | EP0984983B1 Modulators of intracellular inflammation, cell death and cell survival pathways containing a card and a kinase domain |
| 08/17/2005 | EP0975674B1 Immunotoxins, comprising an onc protein, directed against malignant cells |
| 08/17/2005 | EP0972520B1 Freeze-dried composition of bone morphogenetic protein human mp52 |
| 08/17/2005 | EP0939804B1 NEUTROKINE alpha |
| 08/17/2005 | EP0837880B1 Enamel matrix related polypeptide |
| 08/17/2005 | EP0836618B1 Radiometal-binding analogues of leutenizing hormone releasing hormone |
| 08/17/2005 | EP0835128B1 Use of il-11 to treat inflammation |
| 08/17/2005 | EP0832189B1 Process for controlling sialylation of proteins produced by mammalian cell culture |
| 08/17/2005 | EP0784633B1 Process for purifying factor viii |
| 08/17/2005 | EP0760671B1 Peptides used as carriers in immunogenic constructs suitable for development of synthetic vaccines |
| 08/17/2005 | EP0742826B1 Multivariant il-3 hematopoiesis fusion protein |
| 08/17/2005 | CN1656223A Bone generation by gene therapy |
| 08/17/2005 | CN1656222A Antisense iap nucleobase oligomers and uses thereof |
| 08/17/2005 | CN1656205A Stabilization of granules |
| 08/17/2005 | CN1656120A Immunological binding molecules inhibiting the syncytial fusion of trophoblast |
| 08/17/2005 | CN1656119A Peptides capable of inducing attraction to the axonal growth and their use for treating neurodegenerative diseases |
| 08/17/2005 | CN1656115A Gamma-secretase inhibitors |
| 08/17/2005 | CN1656114A Novel pancortin-pablo protein interactions and methods of use thereof |
| 08/17/2005 | CN1656071A New piperidine derivative |
| 08/17/2005 | CN1655845A Use of IL-18 inhibitors for the treatment and/or prevention of peripheral vascular diseases |
| 08/17/2005 | CN1655820A Pharmaceutical combination of PDE5 inhibitors with ace inhibitors |
| 08/17/2005 | CN1655818A Non-peptide CCR1 receptor antagonists in combination with cyclosporin A for the treatment of heart transplant rejection |
| 08/17/2005 | CN1655817A Oxygenating agents for enhancing host responses to microbial infections |
| 08/17/2005 | CN1655812A Anitmicrobial polymer conjugates |
| 08/17/2005 | CN1655811A 组合物及其治疗用途 The composition and therapeutic use |
| 08/17/2005 | CN1655810A Composition for treating or preventing hyperuricemia |
| 08/17/2005 | CN1655809A Compositions and methods for treating and preventing necrosis |
| 08/17/2005 | CN1655804A Method and composition for treating cardiovascular diseases by employing neuroregulation protein |
| 08/17/2005 | CN1655803A Methods of improving central nervous system functioning |
| 08/17/2005 | CN1655802A Bioadhesive directed somatic cell therapy |
| 08/17/2005 | CN1655798A Mixed-cell gene therapy |
| 08/17/2005 | CN1655778A Method for the use of pyranoindole derivatives to treat infection with hepatitis C virus |
| 08/17/2005 | CN1655775A Use of 20-HETE synthesizing enzyme inhibitors as therapy for cerebral vascular disease |
| 08/17/2005 | CN1655764A Compositions and methods for dosing liposomes of certain sizes to treat or prevent disease |
| 08/17/2005 | CN1655692A Alertness bar |
| 08/17/2005 | CN1655675A Combination therapy using trefoil peptides |
| 08/17/2005 | CN1654663A Recombinant human VEGF and bFGF eukaryon expression vector, fused protein and applications thereof |
| 08/17/2005 | CN1654657A Novel streptococcus antigens |
| 08/17/2005 | CN1654653A Novel natural antibacterial peptide HKABF and its preparation and application |
| 08/17/2005 | CN1654652A Amphioxus dimethyl arginine hydrolase AmphiDDAH gene and its application |
| 08/17/2005 | CN1654651A Novel natural antibacterial peptide Hippocampusin and its preparation and application |
| 08/17/2005 | CN1654640A 超氧化物歧化酶组合物及其制备方法 Superoxide dismutase composition and its preparation method |
| 08/17/2005 | CN1654639A Recombinant asparaginase with function of preventing and curing diabetes mellitus |
| 08/17/2005 | CN1654478A Method for preparing polyethylene glycol-modified alpha-interferon 1b |
| 08/17/2005 | CN1654477A Process for preparing transfer factor-heating method |
| 08/17/2005 | CN1654071A Biological fluid film of recombined human keratinized cell growth factor-2 and its preparing process |
| 08/17/2005 | CN1215082C Synthetic peptides useful in biological assays for detecting infections caused by group O HIV-1 viruses |
| 08/17/2005 | CN1215081C Bioactive peptide No.16 |
| 08/17/2005 | CN1214818C Copolymeric micelle drug compsn. and method for the prepn. thereof |
| 08/17/2005 | CN1214815C Composition for stabilizing corneal tissue during or after orthokeratology lens wear |
| 08/17/2005 | CN1214795C Use of vitamin D2 or vitamin D4 derivatives for mfg. medicament for treating secondary hyperparathyroidism |
| 08/17/2005 | CN1214781C Hybrid matrices and hybrid matrix mixtures |
| 08/16/2005 | US6930181 a neuroendocrine protein antigen associated with Type I diabetes mellitus, nucleic acid encoding the protein and methods and reagents for detecting antibody against the protein and identifying individuals at risk of developing Type I diabetes |
| 08/16/2005 | US6930176 Major neutralization site of hepatitis E virus and use of this neutralization site in methods of vaccination and in methods of screening for neutralizing antibodies to hepatitis E virus |
| 08/16/2005 | US6930175 Gene family with transformation modulating activity |
| 08/16/2005 | US6930174 CCR5 chemokine receptor-specific antibodies |
| 08/16/2005 | US6930169 Reducing induced apoptosis; obtain sample, incubate with modulator, monitor sample for reduction in apoptitic activity |
| 08/16/2005 | US6930168 Synthetic peptides to treat an autoimmune demylinating disease e.g., multiple sclerosis; an amino acid sequence having two tyrosine residues and a lysine complex with the myelin basic proteing to modulate an immune response |
| 08/16/2005 | US6930112 Administering antagonist for n-methylaspartic acid or gamma-aminobutyric acid |
| 08/16/2005 | US6930106 Inhibitors of HCV NS5B polymerase |
| 08/16/2005 | US6930094 Tissue factor for influencing blood vessel formation |
| 08/16/2005 | US6930091 growth and activity promotion effects on osteoblasts |
| 08/16/2005 | US6930090 Methods of activating a receptor using amphiphilic drug-oligomer conjugates |
| 08/16/2005 | US6930089 Use of vascular endothelial growth factor, placenta growth factor or both for preventing or treating ischemic disease or stroke |
| 08/16/2005 | US6930088 Conformationally constrained backbone cyclized somatostatin analogs |
| 08/16/2005 | US6930087 Pharmaceutical composition comprising factor VIII and neutral liposomes |
| 08/16/2005 | US6930086 Erythropoietin mutein for use in the treatment of anemia |
| 08/16/2005 | US6930085 G-type peptides to ameliorate atherosclerosis |
| 08/16/2005 | US6930084 Treating arthritis with TNF receptor releasing enzyme |
| 08/16/2005 | US6929955 Interactive system for presenting and eliminating substances |
| 08/16/2005 | US6929948 Lineage specific cells and progenitor cells |
| 08/16/2005 | US6929946 Gene delivery vectors provided with a tissue tropism for smooth muscle cells, and/or endothelial cells |
| 08/16/2005 | US6929941 Chimeric cell-targeting pathogenic organism and method of therapeutic use |
| 08/16/2005 | US6929939 Protein variants that exhibit reduced allergenicity when compared to the parental proteins; cosmetics |
| 08/16/2005 | US6929937 Human transferase proteins and polynucleotides encoding the same |
| 08/16/2005 | US6929932 An isolated polynucleotide molecule encoding an IL-21 antagonist polypeptide of specefic amino acid sequence; culturing |